Bone marrow transplantation in patients with acute leukemia

Caramatti, C.; Mangoni, L.; Carlo-Stella, C.; Rizzoli, V.

Acta Bio-Medica de l'Ateneo Parmense 64(5-6): 213-220

1993


ISSN/ISBN: 0392-4203
PMID: 7992558
Document Number: 415267
At least three factors may be responsible for leukemic relapse in patients receiving ABMT: (a) minimal residual disease; (b) leukemic cells reinfused with the graft; and (c) the lack of a graft-versus leukemia effect. Techniques for pharmacological marrow decontamination, clinical result obtained with ABMT and the efficacy of ABMT with mafosfamide purged marrow in patients with acute myelogenous leukemia are reviewed.

Document emailed within 1 workday
Secure & encrypted payments